U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Wild Edibles Inc. - 10/31/2017
  1. Warning Letters

CLOSEOUT LETTER

Wild Edibles Inc.

Recipient:
Wild Edibles Inc.

United States

Issuing Office:

United States

 

  

Black HHS-Blue FDA LogoOffic Eat
Division 1
www.fda.gov

 

Office of Human and Animal Food Operations East
Division 1

 
 

October 31, 2017

Mr. Robert Martin, President
Wild Edibles, Inc.
740 Barry Street
Bronx, New York 10474

Dear Mr. Martin:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter [NYK 2015-15, December 18, 2014]. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

CDR Catherine Beer
Acting Director, Compliance Branch
Office of Human and Animal Food Operations East – Division 1 

Back to Top